Thrombolex, Inc.

Take the complexity out of addressing Pulmonary Embolism with a safe, clinically proven technology that offers superior efficacy with minimal procedure time. Discover more about the BASHIR? and BASHIR? S-B Endovascular Catheters at Thrombolex.com. #Thrombolex

Thank you to the American Venous Forum team for another exceptional event. For more information regarding Thrombolex's portfolio of endovascular catheters, visit Thrombolex.com #Thrombolex #VENOUS2025 #AVF2025

Join us today at Booth 208 at the American Venous Forum to learn how the BASHIR? Family of Endovascular Catheters can do more for your patients with less drug. Safe, effective, and easy to use, these innovative solutions prove that it’s all in the delivery. #Thrombolex #VENOUS2025 #AVF2025 Thrombolex.com

Visit Thrombolex at Booth 208 during the annual American Venous Forum to learn more about our superior outcomes from the results of the RESCUE-II Trial. ?No need for ICU Infusion ?29.2% Reduction in Pulmonary Artery Obstruction ?No Major Adverse Events ?0% Major Bleeding Rate #Thrombolex #VENOUS2025 #AVF2025 Thrombolex.com

Watch this successful case study treating a pulmonary embolism on-the-table using the BASHIR? Endovascular Catheter. The total treatment time was 40 minutes without an ICU infusion. Final pulmonary artery pressure dropped significantly during the procedure from 78/35 mmHg to 63/17 mmHg. Thrombolex.com #Thrombolex

Join us later this month for the annual American Venous Forum. Discover more about our unique approach to treating arterial and venous thromboembolic disease with the BASHIR? Family of Endovascular Catheters. #Thrombolex #VENOUS2025 #AVF2025 Thrombolex.com

Thank you to the iSET 2025 Conference team for an outstanding event. For more information regarding Thrombolex's unique offering of Endovascular Catheters, visit Thrombolex.com #Thrombolex #iSET2025

“Thanks so much for your invention (the BASHIR? Endovascular Catheter). It saved my daughter’s life.” This heartfelt message from a patient's mother, received by Dr. Riyaz Bashir reminds us why we do what we do at Thrombolex. Pulmonary embolism is a life-threatening condition, and knowing that our innovative platform technology played a role in saving someone’s life fuels our passion and purpose. Thank you for trusting us. Together, we’re making a difference in patients' lives. #Thrombolex #PulmonaryEmbolism https://lnkd.in/eG7WC9S7

Join us today at Booth 400 at iSET 2025 to learn how our innovative catheters can reduce pulmonary artery obstruction by 29.2% and improve patient outcomes. #iSET2025 #Thrombolex Thrombolex.com

At Temple University Hospital, innovation transforms lives. Dr. Riyaz Bashir, interventional cardiologist at Temple University Hospital and professor at Temple University - Lewis Katz School of Medicine, developed the BASHIR? Endovascular Catheter, an FDA-approved technology designed to treat life-threatening pulmonary embolisms. By enabling faster and safer treatment with fewer complications, this breakthrough is setting new standards in patient care. Explore how Temple's innovation is turning ideas into real-world impact: https://bit.ly/4h9th6I